ADVA
ADVA (FSE: ADV) today introduced its OSA 5400 SyncModule™ embedded timing solution, enabling technology suppliers to easily integrate precise synchronization into their hardware. The M.2 form factor module offers equipment vendors a way to simply and cost-effectively add crucial timing capabilities with key functionality into their switches, routers, open compute servers and other IT devices. Featuring GNSS, PTP and NTP engines as well as comprehensive PTP and GNSS monitoring and assurance functionality, the OSA 5400 SyncModule™ empowers third-party companies to leverage the unique expertise of ADVA’s Oscilloquartz synchronization specialists. The solution will provide a major boost to suppliers of mobile infrastructure and white box vendors. It will be key for enabling assured sub-microsecond timing in public and private networks as well as critical infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005094/en/
“Our OSA 5400 SyncModule™ brings something completely new and very valuable to the market. For the first time, third-party technology manufacturers will be able to embed the most advanced synchronization capabilities into their designs and easily control them with our Ensemble Sync Director or their own management system,” said Gil Biran, general manager, Oscilloquartz, ADVA. “With our OSA 5400 SyncModule™ , we’re extending the disaggregated approach to building networks into the area of synchronization. The integrated solution gives vendors the ability to instantly inject the most advanced, highly accurate and fully assured timing into their hardware platforms. As our solution utilizes the widely applied, standardized M.2 interface, integration is simple. It can also easily be added to existing designs.”
The trend towards network disaggregation is accelerating innovation and expanding the market for customers. This does, however, create a challenge for technology suppliers when it comes to synchronization. Now, the OSA 5400 SyncModule™ is filling that gap. The low-power M.2 module gives vendors of emerging technologies, such as open RAN and next-generation data center hardware, the ability to quickly harness the benefits of an integrated GNSS receiver, PTP, NTP and assurance engines, as well as full sync management functionality. Featuring multiple interface options for easy integration, the OSA 5400 SyncModule™ comes with an open API for simple configuration. It can also be managed by ADVA’s proven Ensemble Sync Director management system for complete control of the timing infrastructure.
“Cost-effective and hassle-free, our new embedded timing solution brings highly precise and assured synchronization to a whole new market. For companies who are suppliers of 5G RAN hardware or open compute servers, our OSA 5400 SyncModule™ offers major value,” commented Nir Laufer, VP, product line management, Oscilloquartz, ADVA. “Vendors like those, who are not necessarily experts in network timing, now have the opportunity to instantly pour all of our synchronization know-how into their solutions. And that enables customers to choose the ideal components for their specific needs complete with the best available timing.”
Watch this video to learn more about the OSA 5400 SyncModule™ : https://youtu.be/iPUl_n0dvJU .
Further information is also available in these slides: https://adva.li/osa-5400-syncmodule-slides .
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005094/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Network APIs Pave the Way for Freenow by Lyft to Advance Urban Mobility Innovation22.1.2026 08:00:00 CET | Press release
Freenow adopts Vonage APIs to access network capabilities, strengthening fraud prevention through faster, verified connections with drivers for millions of riders Vonage, a part of Ericsson, and Freenow by Lyft, a leading taxi and multi-mobility app in Europe, have expanded their partnership with the launch of Vonage Silent Authentication API for customers based in the U.S. Vonage Network APIs enable Freenow by Lyft to tap into real-time network data and insights, helping prevent fraud through seamless user verification, ensuring reliable, efficient, and secure interactions for its customers and drivers. Network intelligence is becoming a critical layer of defense in the transportation space as fraud threats become more sophisticated and targeted. Enterprises worldwide lost 7.7% of their annual revenue on average due to fraud over the past year, representing an estimated $534 billion in losses.¹ With scam/authorization fraud, synthetic identity fraud, and account takeover as the leadin
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe22.1.2026 07:30:00 CET | Press release
Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe. Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo. Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology. “Jürgen Müller has made significant scientific contributions that have helped Daiichi Sankyo
Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 202622.1.2026 07:00:00 CET | Press release
Five presentations will showcase nizubaglustat’s therapeutic potential in Lysosomal Storage Disorders. Nizubaglustat is currently being tested in two global Phase 3 studies for Niemann-Pick type C disease and GM1/GM2 gangliosidoses which are currently recruiting. Azafaros will host a satellite symposium on nizubaglustat on Day 2 of the symposium discussing the Phase 3 studies. WORLDSymposium™ 2026 takes place from February 2 to 6 in San Diego, California. Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will feature in five scientific presentations accepted at the WORLDSymposium™ 2026, the leading global conference on lysosomal diseases, taking place in San Diego, California, USA between February 2-6. The company’s conference activities include: Oral Presentations (including Poster numbers 134 and 29-C) Long-term data from a Phase II study wit
I Squared Announces Launch of Radiant Energy Solutions22.1.2026 07:00:00 CET | Press release
I Squared Capital (“I Squared”), a leading global infrastructure investment manager, announced today the launch of Radiant Energy Solutions (“Radiant”), an investment from I Squared’s Middle East infrastructure strategy, which is focused on targeting transformational, mid-market investments in the region. Reflecting I Squared’s platform-building approach of starting with a core initial investment and scaling over time to build market-leading businesses, Radiant marks the firm’s entry into the Middle East distributed renewables market, providing decarbonization solutions to commercial and industrial customers. The investment for Radiant is the acquisition of FAS Renewables and its 100% owned subsidiary Zahra Energy, a Saudi Arabia–based distributed solar company with a secured and advanced portfolio of over 100MWp of distributed solar projects with established customers and long-term contracted solar power purchase agreements. These include Cenomi Centers, an owner, operator, and develo
IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio22.1.2026 07:00:00 CET | Press release
At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas1-7 Multiple studies will reinforce the safety and efficacy of Galderma’s hyaluronic acid (HA) treatments range, including post-marketing data on Restylane® Shaype™ in shaping the chin, Restylane Lyft™ in improving jawline definition, Restylane Skinboosters™ in smoothing fine lines and wrinkles in the décolletage and Restylane Volyme™ in correcting hollowing of the temples8-11 New data on the innovative neuromodulator Relfydess™ (RelabotulinumtoxinA) will reinforce its rapid onset as early as Day 1 and sustained efficacy through six months for frown lines and crow’s feet12 As a leader in injectable aesthetic innovation, Galderma will showcase its superior science and edu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
